Compounded semaglutide is a patient-specific preparation prescribed when clinically appropriate by a licensed provider. Patients can request a confidential telehealth evaluation through the TelosRX Telehealth Portal.
What Is Semaglutide?
Semaglutide is a GLP-1 receptor agonist. It is the active ingredient in commercial brands like Ozempic and Wegovy.
Compounded semaglutide is different. It is prepared by a licensed compounding pharmacy as a patient-specific formulation.
Compounded vs. Commercial Semaglutide
| Feature | Commercial Brand | Compounded |
|---|---|---|
| Source | Novo Nordisk | Licensed compounding pharmacy |
| Formulation | Fixed dose | Patient-specific |
| FDA Approval | Yes, for specific indications | Not FDA-approved; prepared per Rx |
| Use Case | Standard care | When clinically appropriate per provider |
Is Compounded Semaglutide Still Available?
The FDA declared the semaglutide shortage resolved in 2024. This changed the rules for large outsourcing compounding facilities.
Smaller compounding pharmacies operate under different regulations. They may continue to prepare patient-specific compounded semaglutide when a provider determines it is clinically necessary.
How TelosRX Handles Compounded Semaglutide
TelosRX is an online-first telehealth service. Patient evaluation is asynchronous, and compounded medications are prepared through our licensed pharmacy partner.
- Step 1: Complete an asynchronous telehealth intake at TelosRX.
- Step 2: Licensed provider review.
- Step 3: Prescription issued if clinically appropriate.
- Step 4: Compounded semaglutide ships discreetly to your door.
Important Compliance Information
Compounded semaglutide is not FDA-approved. It is prepared under federal compounding regulations.
Prescriptions require evaluation by a licensed healthcare provider. Approval is not guaranteed. Individual results vary.
TelosRX operates under LegitScript-certified telehealth standards.
Start your private evaluation at TelosRX.